Miriam Komaromy, MD, medical director for the Grayken Center for Addiction at BMC, reacts to the news of increased access to a key medication for opioid use disorder.
Despite efforts to combat the opioid epidemic over the past decades, the data shows that death rates have not significantly improved — calling for a paradigm shift in how care is delivered.
Infectious disease physician Josh Barocas will use NIDA grant to create a novel surveillance network for people who use drugs, emphasizing community engagement.
The first multi-site study of the ESC model suggests a nonpharmacologic care model focused on maternal engagement is a safe option for widespread use.
Telemedicine and lower-barrier access to buprenorphine hold potential to make gains against the opioid epidemic after the COVID-19 crisis subsides.